This is the authors' abstract. We don't add key points for this paper.
Oxidative stress (OxS) is one of the main processes related to aging and a common denominator of many different chronic/degenerative diseases (e.g., cardiovascular and neurodegenerative conditions and cancer). Thus, its potential modulation by supplementation/pharmacological therapy caused a lot of interest. However, these expectations have been mitigated by the obtainment of controversial results (beneficial, null, or adverse effects) following antioxidant interventions. Here, we discuss the current understanding of OxS assessment in health and disease, challenges and the potential of its evaluation in clinical practice, and available and future development for supplementation and pharmacologic strategies targeting OxS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vassalle et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: